Cargando…
Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research
Randomized controlled trials’ ability to produce evidence useful for people to decide whether to take, continue taking, or stop taking psychotropic drugs has been intensely critiqued, along with the trials’ commercial, ideological, and regulatory contexts. This article applies the critique to the to...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656873/ https://www.ncbi.nlm.nih.gov/pubmed/33224467 http://dx.doi.org/10.1177/2045125320964097 |